BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

14 articles for TI Richardson

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of potent and selective retinoic acid receptor gamma (RAR¿) antagonists for the treatment of osteoarthritis pain using structure based drug design.EBI
Eli Lilly
Novel 3-Aryl Indoles as Progesterone Receptor Antagonists for Uterine FibroidsEBI
TBA
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety.EBI
Eli Lilly
Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.EBI
Eli Lilly
Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives.EBI
Eli Lilly
Defining Target Engagement Required for Efficacy EBI
Lilly Research Laboratories
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.EBI
Eli Lilly
Pyrimidinone derivatives as SHP2 antagonistsBDB
Merck Patent
Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereofBDB
Sanford Burnham Prebys Medical Discovery Institute
Prolyl hydroxylase inhibitors and methods of useBDB
Akebia Therapeutics
Benzazepine dicarboxamide compoundsBDB
Hoffmann-La Roche
Drugs for treating respiratory diseasesBDB
Daiichi Sankyo
SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.BDB
Instituto De Quimica Medica (Csic)
First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.BDB
Instituto De Quimica Medica (Csic)